
The company acts after FDA reports increased illnesses and deaths linked to its devices
Quick ReadThe company acts after FDA reports increased illnesses and deaths linked to its devices
Quick ReadA new artificial intelligence system unveiled Wednesday by doctors at Johns Hopkins offers to provide a clearer picture for patients: In testing, it displayed a superhuman ability to differentiate harmful lesions from ones that pose no threat at all.
Quick ReadCancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick ReadThe East African country’s campaign to end cervical cancer through the HPV vaccine has had to overcome cultural taboos and rumours about infertility – but it’s saving lives
Quick ReadIn 2010, Dr. Pamela Munster mailed her saliva to 23andMe, a relatively new DNA testing company, and later opted in for a BRCA test. As an oncologist, she knew a mutation of this gene would put her at high risk for breast and ovarian cancer. She was relieved by the negative result
Quick ReadCaregivers aren’t supported, and America overlooks their importance
Quick Read